Address: 23 Novoslobodskaya ulitsa
5e étage, bureau 560
127055 Moscou
Tel: +7 (495) 721 38 28
Web: http://www.ccifr.ru/
The Franco-Russian Chamber of Commerce and Industry (CCIFR) is an independent
lobbying body that represents and promotes the economic interests of its
Franco-Russian member companies.
The CCIFR has been operating in Moscow since 1997, when the Le Club France
was created. The business club developed naturally, becoming the Chamber of Commerce
and Industry in 2006 after becoming a member of the Union of French Chambers
of Commerce and Industry abroad (UCCIFE), the first private network of French
companies in the world, represented in 78 countries and incorporating over 25,000
companies.
Led by a team of permanent professionals under the authority of 18 volunteer
administrators, the CCIFR is a nonprofit association financed mainly by contributions
from its 300 members. Receiving no public subsidies, and not being under any kind
of governmental supervision, the CCIFR is the legitimate, objective and independent
voice of the Franco-Russian business community.
Its work is concentrated in 3 main areas of activity:
• Building the business community: organization and staging of sectoral committees
(Customs/Logistics/Certification, Tax & Accounting, Marketing &
PR, HR), business presentations and B2B meetings, cultural events, and delegations
from regional companies.
• Lobbying: consultations and dialogues with French and Russian private and public
policy makers, with support of its numerous partners (business communities, governments,
politicians and regional organizations). The CCIFR has signed cooperation
agreements with more than fifteen governments and Chambers of Commerce and
Industry in various Russian regions.
• Support for companies: support for establishing and developing French businesses
in Russia, and Russian investment in France.
Although Russian authorities received heavy criticism for approving the Sputnik V vaccine prior to the completion of Phase III clinical trials, the jab is increasingly being seen as a viable…
Russia has announced that a domestically developed COVID-19 vaccine has been approved by its health authorities, the first such approval globally. However, with large-scale Phase III trials having not yet…
Below is a selection of top stories in Russian pharma from recent months, ranging from proposed changes in legislation, labelling system updates, priorities set forth by the country’s manufacturing association…
Russia is facing a drug shortage crisis which is having a particular impact on patients with life-threatening conditions. A combination of geopolitical and bureaucratic issues are restricting the flow of…
In the latest twist in the ongoing story of Russian interference in the US presidential elections of 2016, it has emerged that Russian internet trolls and automated bots spread misinformation…
In the United States, Johnson & Johnson has an image of being very close to people. Americans grow up with this company — from baby shampoo, to Tylenol when they…
You took over this organization just three months ago, having previously headed businesses in industries as diverse as retail, food, and automobiles. What drew you to Alliance Healthcare Russia? Do…
The ARPM was founded in 2002, and you were its director from 2002-2004, before leaving for a post at the Roszdravnadzor. You’ve since rejoined as director since 2007. The organization…
When Focus Reports prepared a report on the French pharmaceutical industry in 2009/10, we found that the head of the main multinational pharmaceutical association had taken a career path quite…
The U.S. and Russia have a long history of trade, and you have personally been with the American Chamber of Commerce in Russia since 2001. Can you give a brief…
The primary objectives of this association are to promote Russia as a clinical trial destination, optimize the regulatory and legislative environment, and promote the interests of ACTO members. Can you…
You have said that AstraZeneca intends to be “in Russia for Russia” and the company has recently announced a large-scale investment in this country, financing a $150Mn domestic facility in…
See our Cookie Privacy Policy Here
